| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/27/2000 | WO1999058657A3 Zea mays phosphate transporter genes and uses thereof |
| 07/27/2000 | WO1999045116A9 Human homolog of a nuclear migration gene and its use |
| 07/27/2000 | CA2363846A1 Removal of prions from blood, plasma and other liquids |
| 07/27/2000 | CA2361276A1 Recombinant sp-a for the treatment or prevention of pulmonary infection and inflammation |
| 07/27/2000 | CA2361272A1 33 human secreted proteins |
| 07/27/2000 | CA2361138A1 Alpha-conotoxin peptides |
| 07/27/2000 | CA2361124A1 Vaccine-mediated treatment of neurological disorders |
| 07/27/2000 | CA2361013A1 Rapid and sensitive detection of aberrant protein aggregation in neurodegenerative diseases |
| 07/27/2000 | CA2360803A1 Lipophilic quenching of viral inactivating agents |
| 07/27/2000 | CA2360770A1 Ras activator nucleic acid molecules - guanine nucleotide releasing factor grf4, polypeptides and methods of use |
| 07/27/2000 | CA2360667A1 Neisseria meningitidis basb054 polypeptides and encoding polynucleotides and uses thereof |
| 07/27/2000 | CA2360658A1 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies |
| 07/27/2000 | CA2360609A1 Basb055 polynucleotide and polypeptide from neisseria meningitidis. uses thereof |
| 07/27/2000 | CA2360065A1 Lipoprotein complexes and compositions containing them |
| 07/27/2000 | CA2360062A1 Baff, inhibitors thereof and their use in the modulation of b-cell response |
| 07/27/2000 | CA2360058A1 Uses of vascular endothelial growth factor in the treatment of erectile dysfunction |
| 07/27/2000 | CA2359681A1 Method of treating chronic cardiac disease |
| 07/27/2000 | CA2359633A1 Homing pro-apoptotic conjugates and methods of using same |
| 07/27/2000 | CA2359490A1 Biological control of nematodes |
| 07/27/2000 | CA2359145A1 Exocytosis pathway proteins and methods of use |
| 07/27/2000 | CA2358963A1 Cancer-associated proteins |
| 07/27/2000 | CA2358930A1 Zsig67: a member of the human secretin-glucagon-vip hormone family |
| 07/27/2000 | CA2358928A1 Megsin promoter |
| 07/27/2000 | CA2358926A1 Endogenetic nucleic fragment associated with an autoimmune disease, marking method and reagent |
| 07/27/2000 | CA2358899A1 Polypeptide |
| 07/27/2000 | CA2358873A1 Human polypeptide having multiple epidermal growth factor (egf) -like domains, zntr2 |
| 07/27/2000 | CA2358800A1 Reagents and methods useful for detecting diseases of the breast |
| 07/27/2000 | CA2358697A1 Polynucleotides and their applications in diagnostics |
| 07/27/2000 | CA2356681A1 Metalloproteinase-disintegrin family members: svph dnas and polypeptides |
| 07/27/2000 | CA2354375A1 Compositions and methods for the diagnosis and treatment of tumor |
| 07/26/2000 | EP1022339A1 Plasmids, their construction and their use in the manufacture of interleukin-4 and interleukin-4 muteins |
| 07/26/2000 | EP1022338A2 Viral vaccines |
| 07/26/2000 | EP1022337A2 Plasmids, their construction and their use in the manufacture of interleukin-4 and interleukin-4 muteins |
| 07/26/2000 | EP1022336A1 POLYPEPTIDE, cDNA ENCODING THE SAME, AND USE OF THEM |
| 07/26/2000 | EP1022333A1 Human tumor suppressor gene |
| 07/26/2000 | EP1022331A2 Transdifferentiation of transfected epidermal basal cells into neural progenitor cells, neuronal cells and/or glial cells |
| 07/26/2000 | EP1022330A2 Transdifferentiation of epidermal basal cells into neural progenitor cells, neuronal cells and/or glial cells |
| 07/26/2000 | EP1022286A1 POLYPEPTIDE, cDNA ENCODING THE POLYPEPTIDE, AND USE OF THE BOTH |
| 07/26/2000 | EP1022285A1 Oxidation-resistant ribonuclease inhibitor |
| 07/26/2000 | EP1022027A1 Tumor necrosis factor antagonists and their use in endometriosis |
| 07/26/2000 | EP1021721A1 Assays for tsh receptor autoantibodies |
| 07/26/2000 | EP1021564A1 Process for detecting, extracting or removing human or mammalian cells with a disturbed cellular cycle regulation or unlimited proliferation or tumour-forming ability |
| 07/26/2000 | EP1021556A1 Assay using marked microbial host cell strains |
| 07/26/2000 | EP1021555A1 STABILIZATION OF $i(HELICOBACTER) UREASE |
| 07/26/2000 | EP1021548A1 Method for introducing and expressing rna in animal cells |
| 07/26/2000 | EP1021547A1 Papilloma virus capsomere vaccine formulations and methods of use |
| 07/26/2000 | EP1021545A2 Dengue virus antigens and treatment of dengue fever |
| 07/26/2000 | EP1021544A2 Chimeric vaccine against tick-borne encephalitis virus |
| 07/26/2000 | EP1021543A1 Mutants of yeast cdc24p, defective in binding of the g-protein beta subunit |
| 07/26/2000 | EP1021542A1 Apo-3 ligand |
| 07/26/2000 | EP1021541A1 Amino-terminally truncated mcp-2 as chemokine antagonists |
| 07/26/2000 | EP1021540A1 Human progesterone receptor complex p23-like protein |
| 07/26/2000 | EP1021539A1 A method for selectively controlling membrane protein display and protein secretion in eukaryotic cells |
| 07/26/2000 | EP1021538A1 Yeast cells expressing modified g proteins and methods of use therefor |
| 07/26/2000 | EP1021537A1 T cell receptor-associated molecules (trams) and methods of use therefor |
| 07/26/2000 | EP1021536A2 Mammalian genes involved in viral infection and tumor suppression |
| 07/26/2000 | EP1021535A2 Human cancer antigen ny eso-1/cag-3 and gene encoding same |
| 07/26/2000 | EP1021534A1 Hepatitis c receptor protein cd81 |
| 07/26/2000 | EP1021533A1 Nucleic acids coding for proteins capable of interacting with presenilins |
| 07/26/2000 | EP1021532A2 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND cDNAs ENCODING THESE PROTEINS |
| 07/26/2000 | EP1021531A2 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND cDNAs ENCODING THESE PROTEINS |
| 07/26/2000 | EP1021530A1 PROTEINS ALIKE TO HUMAN COMPLEMENT FACTOR H AND cDNAs ENCODING THESE PROTEINS |
| 07/26/2000 | EP1021529A2 cDNAs CODING FOR HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS |
| 07/26/2000 | EP1021528A1 Methods of refolding proteins by use of zwitterionic low molecular weight agents |
| 07/26/2000 | EP1021527A1 Plant and viral promoters |
| 07/26/2000 | EP1021526A1 GENE DELETED RECOMBINANT FeLV PROVIRAL DNA FOR PRODUCTION OF VACCINES AGAINST FeLV |
| 07/26/2000 | EP1021465A2 Gfp-annexin fusion proteins |
| 07/26/2000 | EP1021464A1 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle |
| 07/26/2000 | EP1021462A1 Assays for nuclear receptor ligands using fret |
| 07/26/2000 | EP1021461A1 Use of neuronal and lymphocytic potassium canal inhibitors for treating neurological diseases of immune origin |
| 07/26/2000 | EP1021460A1 Laminins and uses thereof |
| 07/26/2000 | EP1021458A1 Helicobacter polypeptides and corresponding polynucleotide molecules |
| 07/26/2000 | EP1021202A1 Immunogenic peptides from the hpv e7 protein |
| 07/26/2000 | EP1021201A1 Use of growth differenciation factor-9 (gdf-9) as a contraceptive |
| 07/26/2000 | EP1021080A1 Coat protein mediated resistance in plants |
| 07/26/2000 | EP1007964A4 FORMATION AND USE OF PRION PROTEIN (PrP) COMPLEXES |
| 07/26/2000 | EP0904541A4 PURIFICATION OF TISSUE PLASMINOGEN ACTIVATOR (tPA) |
| 07/26/2000 | EP0832134B1 Anti-allergy bispecific molecules |
| 07/26/2000 | EP0786084A4 Method for screening compositions |
| 07/26/2000 | EP0769054B1 Immunomodulators |
| 07/26/2000 | CN1261404A Lentivirus-Based gene transfer vectors. |
| 07/26/2000 | CN1261403A Surface exposed proteins from chlamydia pneumoniae |
| 07/26/2000 | CN1261402A Plant and viral promotors |
| 07/26/2000 | CN1261284A Use of a CD40 : CD154 binding interruptor to prevent counter adaptive immune responses, particularly graft rejection |
| 07/26/2000 | CN1261281A Peptide parathyroid hormone analogs |
| 07/26/2000 | CN1261105A Human gene pRb-BP125 reacting on anticancer gene coding resultant pRB |
| 07/26/2000 | CN1261104A Human oxido-reductase subunit and its coding sequence, preparing process and application |
| 07/26/2000 | CN1261103A Human targeting glycogen protein,and its coding sequence, preparing process and application |
| 07/26/2000 | CN1261102A Human spindle protein and its coding sequence, preparing process and application |
| 07/26/2000 | CN1261101A Method for dwarfing plants |
| 07/26/2000 | CN1261075A Recombination virus able to specifically kill tumor cells associated with EB virus and building process |
| 07/26/2000 | CN1054857C Motilin-like polypeptides with gastrointinal motor stimulating activity |
| 07/25/2000 | US6093874 Methods for improving seeds |
| 07/25/2000 | US6093810 Nematode-induced genes in tomato |
| 07/25/2000 | US6093808 IκBEGFP constructs, cell lines and methods of use |
| 07/25/2000 | US6093806 DNA encoding proteins of Kaposi's sarcoma associated herpesvirus |
| 07/25/2000 | US6093804 Method for purification of alpha-1 proteinase inhibitor |
| 07/25/2000 | US6093803 Method of producing aminoterminal propeptide of type 1 procollagen |
| 07/25/2000 | US6093802 Culturing cells transformed to express a nerve growth factor of specific amino acid sequence, activity, or weight and isolating protein; for treatment of alzheimer's/parkinson's diseases, amyotrophic lateral sclerosis, and nerve damage |
| 07/25/2000 | US6093801 Recombinant analogs of bactericidal/permeability increasing protein |